Skip to main navigation Skip to search Skip to main content

A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma.

  • Edward Pan
  • , Daohai Yu
  • , Binglin Yue
  • , Lisa Potthast
  • , Sajeel Chowdhary
  • , Pamela Smith
  • , Marc Chamberlain

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalJournal of neuro-oncology
Volume110
DOIs
StatePublished - Jul 26 2012
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gastroenterology
  • Surgery
  • Internal Medicine

Cite this